middle.news
Ceretas targets $8 million IPO to advance Alzheimer’s ultrasound therapy
4:53pm on Tuesday 21st of July, 2026 AEST
•
Healthcare
Read Story
Ceretas targets $8 million IPO to advance Alzheimer’s ultrasound therapy
4:53pm on Tuesday 21st of July, 2026 AEST
Key Points
IPO to raise $8 million at $0.25 per share
Device targets behavioural symptoms of Alzheimer’s via neuromodulation
Phase 1 trial showed safety and preliminary efficacy
Two Phase 2 trials underway with ethics approval
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CERETAS (ASX:CTS)
OPEN ARTICLE